ATTD Conference Brings World-Renowned Minds to Berlin, Germany
This year’s Advanced Technologies & Treatments for Diabetes (ATTD) meeting, held February 22-25, will have 45 presenters who are or…
“I Really Love Type 1 Diabetes Research, and I’m Not Going Back”
A goal of David Alagpulinsa, Ph.D., is to contribute to a treatment that makes people with type 1 diabetes live…
FDA Authorizes Tidepool Loop, an Automated Insulin Dosing App
The FDA authorized the Tidepool Loop, an algorithm that could be used to work with commercially available insulin pumps and…
Interview: I’ve Got Hope Back in my Life
The Mary Tyler Moore Vision Initiative has a lofty goal: To halt and reverse vision loss from diabetes. Here’s one…
Dexcom G7 Continuous Glucose Monitor Cleared by the FDA
Dexcom G7® Continuous Glucose Monitor system was cleared by the FDA, giving people with diabetes more options for managing their…
FDA Approves Tzield™—A Watershed Moment for the T1D Community
Breakthrough T1D celebrates the FDA approval of Tzield, the first disease-modifying therapy to delay clinical T1D in people at risk…
Breakthrough T1D and ISPAD Announce 2022 Drash Fellows
Congratulations to the 2022 Fellows!
The Innovative Insulin Your Kids Can’t Use…Yet
What if it was safe and effective to take a rapid-acting inhaled insulin in children/teens as they start eating? The…
Top Scientists Unite at the EASD Annual Meeting
Leading researchers gathered for the annual meeting of the EASD, at which more than 30 studies were presented by Breakthrough…
EASD Meeting Brings Together World-Renowned Minds in Diabetes Research
Leading researchers from around the world will gather for the annual meeting of the European Association for the Study of…
